Skip to Main Content

Rise and shine, another busy day is on the way. We can tell because the short person has emerged to get a jump on schoolwork due in a few weeks and the official mascot is noisily bounding about the official Pharmalot grounds. As for us, we are watching our to-do list lengthen and trying to keep track of Zoom calls. Perhaps you can relate. Meanwhile, time for another cup of stimulation. Our choice today is maple bourbon. And of course, here are a few tidbits to get you going. Hope all goes well today, and do keep in touch. One more thing, wear a mask. …

Given the prevailing business-centric model of American drug pricing, a Covid-19 vaccine could well be budget-breaking, perhaps making it unavailable to many, Kaiser Health News writes. The concern emerges at a time when drug development is one of the world’s most lucrative businesses, ownership of drug patents is disputed in endless court battles, and monopoly power often lets manufacturers set any price, no matter how extraordinary — and the American government has no effective way to fight back.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!